Related Experiment Video
Updated: Apr 28, 2026

A Unified Methodological Framework for Vestibular Schwannoma Research
Published on: June 20, 2017
Conservative management of vestibular schwannoma
Ricardo José González-Orús Álvarez-Morujo1, Itziar Alvarez-Palacios1, Carlos Martin-Oviedo1
1Servicio de ORL, Hospital General Universitario Gregorio Marañón, Madrid, España.
Introduction:
Vestibular schwannoma (VS) is a benign, slow-growing tumour originating in the 8th cranial nerve. The treatment includes microsurgery, stereotactic radiotherapy and conservative management of tumours with periodic radiological tests.
Methods:
This was a retrospective study of patients with VS following conservative management in a tertiary hospital between 1993 and 2013. A total of 73 patients were enrolled in our protocol. The mean age at diagnosis was 59.7 years. The average size was 11.9mm (4-27mm); 58.9% of the tumours were intracanalicular and 41.1%, extracanalicular. The mean follow-up period was 35.75 months.
Results:
In 87.7% of patients there was no evidence of tumour growth. A total of 9 tumours (12.3%) increased in size. The average growth rate was 0.62mm/year. The percentage of extracanalicular tumours that grew (20%) was higher than that of intracanalicular tumours (7%). Seven patients (9.5%) experienced significant changes in their symptoms and 6 of these (8.2%) experienced a loss of useful hearing. Six patients (8.2%) left follow-up and underwent surgery.
Conclusions:
Periodic monitoring of vestibular schwannomas with magnetic resonance imaging represents an option for management, because most small tumours experience little or no growth over time.
Related Concept Videos
Mitral Stenosis III: Medical Management
Mitral Valve Prolapse III: Nursing Management
Mitral Regurgitation III: Medical Management
Aneurysm IV: Nursing Management
Mitral Stenosis IV: Nursing Management
The Vestibular System

